相关实验视频

Updated: Aug 3, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

用于质瘤治疗的声动疗法和声敏剂:系统的定性审查

Neel H Mehta¹, Harshal A Shah², Randy S D'Amico²

¹Department of Biology, Cornell University, Ithaca, New York, USA.

World neurosurgery

|July 16, 2023

概括

超声波疗法 (SDT) 通过使用超声波来激活药物来治疗质瘤,从而导致瘤细胞死亡. 本综述涵盖了临床前数据,重点是SDT.

科学领域:

生物医学工程生物医学工程
在瘤学瘤学.
光动力学疗法光动力学疗法

背景情况:

声动疗法 (SDT) 是一种正在发展中的质瘤的非侵入性治疗方法.
声敏剂和方案的变化需要对当前的临床前数据进行审查.

研究的目的:

系统地审查关于SDT在质瘤治疗中的疗效的临床前和早期临床数据.
为了巩固关于质瘤治疗的声敏化剂和超声协议的发现.

主要方法:

对临床前和早期临床研究的系统文献综述.
用SDT治疗的体外和体内质瘤模型的分析.

主要成果:

与聚焦超声波相结合的声敏化剂 (例如5 - 氨基风氨酸,5 - 氨基风氨酸,5 - 氨基风氨酸,5 - 氨基风氨酸) 显示出显著的抗瘤作用.
质瘤细胞中的细胞毒性活动是由氧化应激,活性氧物种,亡和过载介导的.

结论:

在临床前的质瘤模型中,SDT表现出强大的疗效.
对SDT机制的进一步研究和临床试验对于优化质瘤治疗至关重要.

关键词:

5-5-ALAALA 是一个很好的方法.质瘤是一种质瘤.这是SDT SDT.声动力学疗法声动力学疗法

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System

Published on: February 10, 2023

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...